What is KRRO stock price today?

KRRO (Korro Bio Inc) stock is trading at $13.69 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is KRRO stock going up or down today?

KRRO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy KRRO stock now?

The decision to buy KRRO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is KRRO a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for KRRO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is KRRO stock overvalued or undervalued?

Use our DCF valuation calculator to determine if KRRO is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is KRRO's P/E ratio?

P/E ratio data for KRRO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is KRRO's market cap?

KRRO (Korro Bio Inc) has a market capitalization of $0.18 billion, making it a small-cap stock.

What is KRRO's price to book ratio?

KRRO trades at a price-to-book (P/B) ratio of 3.56, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does KRRO pay dividends?

KRRO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is KRRO's dividend yield?

KRRO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is KRRO stock a good long-term investment?

KRRO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is KRRO's revenue growth rate?

KRRO has shown revenue growth of -0.4% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for KRRO are available on our dashboard with complete income statement analysis.

What are the risks of investing in KRRO?

Key risks for KRRO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does KRRO compare to its competitors?

Compare KRRO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize KRRO's performance and positioning.

What is KRRO's stock price target for 2026?

Our AI model provides price targets for KRRO based on fundamental analysis: Bull case $17.80 (+30%), Base case $15.74 (+15%), Bear case $12.32 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about KRRO?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for KRRO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is KRRO's next earnings report?

KRRO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

KRRO - Korro Bio Inc

NYSE * Health Care * Biotechnology

$13.69

+$1.01 (+7.97%)

About Korro Bio Inc

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

KRRO Key Statistics

Market Cap

$182.88M

P/B Ratio

3.56

EPS

$-12.48

Revenue Growth

-0.4%

Employees

How KRRO Compares to Peers

KRRO is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
KRRO(This stock)	$182.88M	N/A	-0%	0.0%	-
AMGNAmgen Inc	$188.58B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$172.56B	20.5	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$111.93B	28.7	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$78.92B	18.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$25.88B	20.1	-0%	0.1%	vs BIIB

Korro Bio Inc Company Information

Headquarters: Massachusetts; U.S.A
Website: www.korrobio.com
Sector: Health Care
Industry: Biotechnology

KRRO - Korro Bio Inc

About Korro Bio Inc

KRRO Key Statistics

How KRRO Compares to Peers

Korro Bio Inc Company Information

KRRO Lician Score

KRRO Financial Snowflake

Upcoming Events for KRRO